Clinical evaluation of an over-the-counter hearing aid (TEO First®) in elderly patients suffering of mild to moderate hearing loss

Presbycusis has a direct influence on autonomy of the elderly but hearing aids lack of affordability. Moreover a recent review demonstrate that electroacoustic characteristics of OTC hearing aids were generally not suitable for the elderly people. In our study, we assessed the clinical value of a ne...

Full description

Saved in:

Bibliographic Details
Published in:	BMC geriatrics Vol. 16; no. 1; p. 136
Main Authors:	Sacco, Guillaume, Gonfrier, Sébastien, Teboul, Bernard, Gahide, Ivan, Prate, Fredéric, Demory-Zory, Mathilde, Turpin, Jean-Michel, Vuagnoux, Claire, Genovese, Philippe, Schneider, Stéphane, Guérin, Olivier, Guevara, Nicolas
Format:	Journal Article
Language:	English
Published:	England BioMed Central Ltd 09-07-2016 BioMed Central
Subjects:	Activities of daily living Aged Aged patients Audiology Audiometry Care and treatment Ears & hearing Equipment Design Evaluation Female Follow-Up Studies Geriatrics Hearing aids Hearing Aids - standards Hearing loss Hearing Loss - diagnosis Hearing Loss - physiopathology Hearing Loss - rehabilitation Hospitals Humans Informed consent Male Middle Aged Noise Older people Patient Satisfaction Patients Presbycusis Prospective Studies Prostheses Quality of Life Severity of Illness Index Signal processing Sound Surveys and Questionnaires France United States > US OTC Hearing aid Elderly Hearing rehabilitation
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Presbycusis has a direct influence on autonomy of the elderly but hearing aids lack of affordability. Moreover a recent review demonstrate that electroacoustic characteristics of OTC hearing aids were generally not suitable for the elderly people. In our study, we assessed the clinical value of a new over-the-counter (OTC) hearing aid device (TEO First®) in the elderly. This prospective monocentric open label study included patients over 60 years of age with a mild to moderate presbycusis. Patients were assessed with acceptable noise level test (ANL), pure tone (PTA) and speech (SA) audiometry in silent and noisy environment, with and without TEO First®. A Glasgow Hearing Aid Benefit Profile, acceptability and satisfaction surveys were completed after one month of using the device. Thirty one patients were included. There was an improvement of hearing with TEO First® in silence (SA: +39.2 %, p < 0.01; PTA: -9.04 dB, p < 0.01) or in noise (SA +47.7 %, p < 0.01; PTA: -5.23 dB, p < 0.05). After one month of use of the device, quality of life has improved with regards to the following parameters: decrease of perceived hearing difficulties during conversation without background noise (-9.6 % p = 0.018), in conversation with several people (-16.2 % p = 0.0076), decrease of negative emotions while watching TV (-18.5 % p = 0.011), during conversation without background noise (-16.5 % p = 0.0024), during conversation in noisy background (-17.1 % p = 0.027) and during conversation with several people (-20 % p = 0.014). The acceptability of the device was low to moderate. TEO First® is an effective OTC hearing aid that improves the patient's quality of life. Current Controlled Trials NCT01815788.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23
ISSN:	1471-2318 1471-2318
DOI:	10.1186/s12877-016-0304-4